This research reveals that KMUP-1 co- and posttreatment could inhibit atherosclerotic plaque formation and atherosclerosis lesions by suppressing inflammation in HFD-fed mice (i.e., elevation of IL-1β and TNF-α). This evidence concerns the gene IL1B and atherosclerosis.